Work

A pilot study of PLX3397, a selective colony-stimulating factor 1 receptor (CSF1R) kinase inhibitor, in pigmented villonodular synovitis (PVNS).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.10503

Authors: William D. Tap, Stephen Patrick Anthony, Bartosz Chmielowski, Arthur P. Staddon, Allen Lee Cohn, Geoffrey Shapiro, Igor Puzanov, Eunice L Kwak, Andrew J Wagner, Charles Peterfy, Henry H Hsu, Carolyn Gee, Paul S. Lin, Sandra Tong, Zev A. Wainberg

Institutions: Memorial Sloan Kettering Cancer Center, University of California, Los Angeles, University of Pennsylvania, Rocky Mountain Cancer Centers, Dana-Farber Cancer Institute, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Massachusetts General Hospital, Plexxikon (United States)

Language: English

Topic: Musculoskeletal synovial abnormalities and treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2237909979

Cites:

Cited by: 12

Related to: 10